Peter Vandenberghe

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Ross L. Levine, Martha Wadleigh, Jan Cools et al. · Cancer Cell · 2005 · 3K citations · Full text

Medicine, Genetics, Hematology +14

A Tyrosine Kinase Created by Fusion of the <i>PDGFRA</i> and <i>FIP1L1</i> Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

Jan Cools, Daniel J. DeAngelo, Jason Gotlib et al. · New England Journal of Medicine · 2003 · 1.7K citations · Full text

Life Sciences, Genetics, Hematology +15

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

Frederick L. Locke, David B. Miklos, Caron A. Jacobson et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

Medicine, Hematology, Oncology +8

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

Peter Valent, Amy D. Klion, Hans‐Peter Horny et al. · Journal of Allergy and Clinical Immunology · 2012 · 761 citations · Full text

Medicine, Pathology, Dermatopathology +8

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

Gorica Nikoloski, Saskia Langemeijer, Roland P. Kuiper et al. · Nature Genetics · 2010 · 748 citations

Life Sciences, Genetics, Molecular Genetics +16